Eli Lilly announced the election of Nobel Laureate Carolyn R. Bertozzi, Ph.D., as a returning member of its board of directors, effective December 8, 2025. She will serve on the Science and Technology and Ethics and Compliance committees. LLY closed at $981.89 on December 9, 2025, showing a 7-day downtrend, but this specific governance news is unlikely to be the primary driver of the recent moderate stock decline.